Brigitte Bär

545 total citations
16 papers, 438 citations indexed

About

Brigitte Bär is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Brigitte Bär has authored 16 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 6 papers in Immunology and 4 papers in Genetics. Recurrent topics in Brigitte Bär's work include Hematopoietic Stem Cell Transplantation (13 papers), T-cell and B-cell Immunology (5 papers) and Acute Myeloid Leukemia Research (3 papers). Brigitte Bär is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), T-cell and B-cell Immunology (5 papers) and Acute Myeloid Leukemia Research (3 papers). Brigitte Bär collaborates with scholars based in Netherlands, Belgium and Egypt. Brigitte Bär's co-authors include A Schattenberg, T. de Witte, Nicolaas Schaap, Ad Geurts van Kessel, E. J. B. M. Mensink, Toon F.C.M. Smetsers, Frank Preijers, Boukje A. C. van Dijk, V.A.J.M. Kunst and Richard van der Maazen and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Haematology and Leukemia.

In The Last Decade

Brigitte Bär

16 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Bär Netherlands 12 379 157 95 63 57 16 438
Valda Thomas South Africa 9 246 0.6× 154 1.0× 99 1.0× 41 0.7× 66 1.2× 22 350
Kun Soo Lee South Korea 12 287 0.8× 126 0.8× 98 1.0× 43 0.7× 60 1.1× 43 449
K-W Sykora Germany 8 279 0.7× 122 0.8× 43 0.5× 84 1.3× 50 0.9× 9 351
RB Geller United States 9 301 0.8× 101 0.6× 83 0.9× 69 1.1× 39 0.7× 11 358
Dag Heldal Norway 10 287 0.8× 179 1.1× 89 0.9× 59 0.9× 161 2.8× 17 416
Rose Marie Hamladji Algeria 8 379 1.0× 87 0.6× 106 1.1× 93 1.5× 102 1.8× 10 417
L-P Xu China 10 354 0.9× 164 1.0× 96 1.0× 84 1.3× 52 0.9× 14 400
M A Kharfan-Dabaja United States 10 235 0.6× 77 0.5× 85 0.9× 64 1.0× 47 0.8× 24 322
T Chauncey United States 9 330 0.9× 98 0.6× 133 1.4× 45 0.7× 52 0.9× 12 362
A. Ferster Belgium 9 232 0.6× 92 0.6× 76 0.8× 36 0.6× 51 0.9× 11 370

Countries citing papers authored by Brigitte Bär

Since Specialization
Citations

This map shows the geographic impact of Brigitte Bär's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Bär with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Bär more than expected).

Fields of papers citing papers by Brigitte Bär

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Bär. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Bär. The network helps show where Brigitte Bär may publish in the future.

Co-authorship network of co-authors of Brigitte Bär

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Bär. A scholar is included among the top collaborators of Brigitte Bär based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Bär. Brigitte Bär is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Velden, Walter J. F. M. van der, Joop H. Jansen, Brigitte Bär, et al.. (2021). Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 56(8). 1964–1970. 7 indexed citations
2.
Boome, Liane te, Inger S. Nijhof, Suzanne van Dorp, et al.. (2018). Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib. Bone Marrow Transplantation. 53(10). 1255–1262. 14 indexed citations
3.
Hobo, Willemijn, Walter J. F. M. van der Velden, Manita Bremmers, et al.. (2016). Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses. Biology of Blood and Marrow Transplantation. 22(6). 1000–1008. 39 indexed citations
4.
Wiersum‐Osselton, Johanna C., Suzanna M. van Walraven, Tanja Netelenbos, et al.. (2016). Donors’ health state the year after peripheral haematopoietic progenitor cell collection: A prospective follow‐up study in related and unrelated donors compared to first‐time platelet donors. Journal of Clinical Apheresis. 31(6). 523–528. 1 indexed citations
6.
Schaap, Nicolaas, A Schattenberg, Brigitte Bär, et al.. (2000). Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T‐cell‐depleted bone marrow transplantation and after donor leucocyte infusion. British Journal of Haematology. 108(1). 116–125. 23 indexed citations
7.
Schattenberg, A, Nicolaas Schaap, E. van de Wiel-van Kemenade, et al.. (1999). In Relapsed Patients after Lymphocyte Depleted Bone Marrow Transplantation the Percentage of Donor T Lymphocytes Correlates Well with the Outcome of Donor Leukocyte Infusion. Leukemia & lymphoma. 32(3-4). 317–325. 21 indexed citations
8.
Schattenberg, A, E. J. B. M. Mensink, Brigitte Bär, et al.. (1997). Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase. Bone Marrow Transplantation. 19(12). 1205–1212. 17 indexed citations
9.
Schaap, Nicolaas, A Schattenberg, Brigitte Bär, et al.. (1997). Outcome of transplantation for standard‐risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen. British Journal of Haematology. 98(3). 750–759. 37 indexed citations
10.
Bär, Brigitte, et al.. (1995). Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.. PubMed. 16(6). 793–9. 39 indexed citations
11.
Bär, Brigitte, A Schattenberg, E. J. B. M. Mensink, et al.. (1993). Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.. Journal of Clinical Oncology. 11(3). 513–519. 139 indexed citations
13.
Bär, Brigitte, T. de Witte, A Schattenberg, J.B.M. Boezeman, & J. Hoogenhout. (1990). Favourable outcome of patients older than 40 years of age after transplantation with marrow grafts depleted of lymphocytes by counterflow centrifugation. British Journal of Haematology. 74(1). 53–60. 14 indexed citations
14.
Bär, Brigitte, et al.. (1989). Host and donor erythrocyte repopulation patterns after allogeneic bone marrow transplantation analysed with antibody‐coated fluorescent microspheres. British Journal of Haematology. 72(2). 239–245. 24 indexed citations
15.
Bär, Brigitte, et al.. (1989). Impact of ciprofloxacin and cotrimoxazole on bone marrow growth as measured by CFU-GM and BFU-E assays.. PubMed. 1(4 Suppl). 606–7. 2 indexed citations
16.
Bär, Brigitte, et al.. (1986). Primary Malignant Lymphoma of the Uterine Cervix Associated with Cold-Reacting Autoantibody-Mediated Hemolytic Anemia. Acta Haematologica. 75(4). 232–235. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026